About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 40 record(s)
Req # A-2021-10668
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and The Canadian Forus for Rare Disease Innovators (RAREi) over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 9, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
September 2021
Req # A-2021-10669
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Purdue Pharma (Canada) over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
September 2021
Req # A-2021-10670
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Eczema Society of Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
September 2021
Req # A-2021-10671
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and PHA Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 8, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
September 2021
Req # A-2019-01244
Copy of all internal memos, policies and training materials both public and government-held (in the possession of and under the control of the Immigration and Refugee Board) regarding the topics of Section 15 of the Canadian Charter of Rights and Freedoms, unconscious bias, race equity training, diversity and inclusions, persons with disability, sexual orientation and intersectionality. Specifically we would like to obtain relevant training materials utilized by IRB Board Members on these topics. We are requesting final current copies and latest drafts within the past five years (January 1, 2014 to September 3, 2019)Organization: Immigration and Refugee Board of Canada
September 2020
Req # A-2019-01351
My request concerns the "Report of the 2017/2018 External Audit (Detention Review)", found at the following link: https://irb-cisr.gc.ca/en/transparency/reviews-audit-evaluations/Pages/ID-external-audit-1718.aspx (the “Report”) The aforementioned Report discusses evidence and files on which the report was based, such as the “20 files with respect to 18 individuals held in immigration detention” mentioned at footnote 2, 30-day review hearing tapes mentioned at footnote 7, the “Case Review” mentioned at footnote 43, and several others. I would like to access the specifically noted evidence and files, as well as all the other underlying evidence, files, and materials on which the report is based.Organization: Immigration and Refugee Board of Canada
September 2020
Req # A-2020-00516
All Immigration Division admissibility decisions and reasons for Egyptian Citizens rendered on the basis of section 34(1)(f) of the Immigration and Refugee Protection Act between January 1, 2017, and August 15, 2020. Please provide all physical and electronic filesOrganization: Immigration and Refugee Board of Canada
September 2020
Req # A-2020-00004
List of mandatory or voluntary training, info sessions, awareness sessions, and sensitivity training from January 1, 2020 to September 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-04135
Copies of the Human Drug Advisory (HDAP) report for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
September 2020
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020